Go to content
Core Laboratories N.V.

Core Laboratories N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 12 mei 2016 - 02:28
Statutaire naam Core Laboratories N.V.
Titel CORE LAB ANNOUNCES UPSIZING AND PRICING OF PUBLIC OFFERING OF COMMON STOCK
Bericht Core Laboratories N.V. (NYSE: “CLB US”) (Euronext Amsterdam: "CLB NA") announced the upsized pricing of an underwritten public offering of 1,475,000 shares of its common stock. The underwriter intends to offer the shares from time to time for sale in one or more transactions on the New York Stock Exchange or the Euronext Amsterdam, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. The total gross proceeds of the offering (before underwriter's discounts and commissions and estimated offering expenses) will be approximately $175 million. Core Lab granted the underwriter a 30-day option to purchase up to 221,250 additional shares of its common stock. The offering is expected to close on May 17, 2016, subject to customary closing conditions.

Datum laatste update: 16 december 2025